Role of leukotrienes in post-allergic propranolol-induced bronchoconstriction in guinea-pigs

Clinical and Experimental Allergy

Volumn 27, Issue 10, 1997, Pages 1219-1226

  Fujimura, M ^a   Songur N ^a   Ishiura, Y ^a   Mizuhashi, K ^a   Myou, S ^a   Matsuda, T ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Allergic bronchoconstriction; Leukotriene B4; Propranolol induced bronchoconstriction; Sulfidopeptide leukotrienes

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEPTIDOLEUKOTRIENE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSPASM; CONTROLLED STUDY; GUINEA PIG; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ATROPINE; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; GUINEA PIGS; HYPERSENSITIVITY, IMMEDIATE; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MALE; MUSCARINIC ANTAGONISTS; NEUTROPHILS; OVALBUMIN; PHENTOLAMINE; PROPRANOLOL;

EID: 0030756661     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01160.x     Document Type: Article

References (31)

1. Ruffin RE, McIntyre EL, Latimer KM et al. Assessment of β-adrenoreceptor antagonists in asthmatic patients. Br J Clin Pharmacol 1982; 13:325-35.
2. Langer I. The bronchoconstrictor action of propranolol aerosol in asthmatic subjects. J Physiol 1967; 190:41-4.
3. McNeill RS. The effect of propranolol on airway resistance. Br J Anaesth 1967; 39:919-25.
4. McDonald AG, Ingram CG, McNeill RS. Effect of beta-adrenergic-blocking agent, propranolol, on asthmatics. Lancet 1964; 11:1101-2.
5. 2 in propranolol-induced bronchoconstriction in guinea pigs. Am J Respir Dis Crit Care Med 1994; 149:1488-93.
6. Ind PW, Dixon CM, Fuller RW, Barnes PJ. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am Rev Respir Dis 1989; 139:1390-4.
7. Terpstra GK, Raaijmakers JA, Wassink GA. Propranolol induced bronchoconstriction: A nonspecific side effect of beta adrenergic blocking therapy. Eur J Pharmacol 1981; 73:107-8.
8. Fujimura M, Sakamato S, Nishi K et al. Inhibitory effect of inhaled procaterol on anaphylactic bronchoconstriction and thromboxane production in guinea pigs. Clin Exp Allergy 1991; 21:189-94.
9. Abraham WM, Burch RM, Farmer SG et al. A bradykinin antagonist modifies allergen induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis 1991; 143:787-96.
10. Dworski R, Sheller JR, Wickersham NE et al. Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid: Effect of cyclooxygenase inhibition. Am Rev Respir Dis 1989; 139:46-51.
11. Okayama H, Aikawa T, Ohtsu H, Sasaki H, Takishima T. Leukotrienes C4 and B4 in bronchoalveolar lavage fluid during biphasic allergic bronchoconstriction in sheep. Am Rev Respir Dis 1989; 139:725-31.
12. 4 excretion during antigen induced bronchoconstriction in allergic sheep. J Appl Physiol 1990; 68:1321-7.
13. Carpentiere G, Castello F, Marino S. Effect of oral terfenadine on the bronchoconstrictor response to inhaled propranolol in asthmatics. Curr Ther Res 1991; 49:503-7.
14. Songur N, Fujimura M, Mizuhashi K, Saito M, Matsuda T. Effect of a 5-lipoxygenase inhibitor, AL-3264, on propranolol-induced bronchoconstriction in guinea pigs. J Lipid Mediat Cell Signal 1995; 11:175-85.
15. Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988; 81:711-7.
16. Samuellson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammations. Science 1983; 220: 568-75.
17. 4 on mucociliary and respiratory function in allergic and nonallergic sheep. J Appl Physiol 1985; 59:1416-22.
18. 4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982; 126:449-51.
19. Bray MA. Leukotrienes in inflammation. Agents Actions 1986; 19:87-99.
20. 4-receptor antagonist. Eur J Pharmacol 1990; 191:273-80.
21. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (London) 1980; 286:264-5.
22. Abraham WM, Ahmed A, Cortes A et al. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. Eur J Pharmacol 1992; 217:119-26.
23. Kishikawa K, Tateishi N, Maruyama T et al. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions. Prostaglandins 1992; 44:261-75.
24. Snyder DW, Giles RE, Keith RA, Yee YK, Krell RD. In vitro pharmacology of ICI, 198,615: a novel, potent and selective peptide leukotriene antagonist. J Pharmacol Exp Ther 1987; 243:548-56.
25. Santives T, Roska A, Hensley GT et al. Immunologically induced lung disease in guinea pig. J Allergy Clin Immunol 1976; 57:582-94.
26. Konzett H, Rossler R. Versuchanordnungzu Untersuchungen an der Bronchialmusculatur. Arch Exp Path Pharmak 1940; 195:71-4.
27. Jones T, Masson P, Hamel R et al. Biological activity of leukotriene sulfones on respiratory tissues. Prostaglandins 1982; 24:279-91.
28. Fujimura M. Inhibitory effect of steroids on slow reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction in guinea pigs. Jpn J Allergol 1983; 32:365-75.
29. Minami S, Okafuji K, Saga T et al. A new quantitative inhalation apparatus for small animals. Jpn J Chest Dis 1983; 21:252-8.
30. Latimer KM, Ruffin RE. The effect of inhaled fenoterol and ipratropium bromide on propranolol induced bronchoconstriction in the asthmatic airways. Clin Exp Pharmacol Physiol 1990; 17:627-35.
31. Okayama M. Yafuso N, Nogami H et al. A new method of inhalation challenge with propranolol. J Allergy Clin Immunol 1987; 80:291-9.